BVT Discount Zert BIIB 27.09.2024/ DE000VD39P40 /
| 30/07/2024 16:51:29 | Chg.+0.240 | Bid18:01:09 | Ask18:01:09 | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 155.390EUR | +0.15% | 155.310 Bid Size: 3,200 |
155.510 Ask Size: 3,200 |
Biogen Inc | - USD | 27/09/2024 | Call |
GlobeNewswire
02/07
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
01/07
Contact The Gross Law Firm by July 22, 2024 Deadline to Join Class Action Against Biogen Inc.(BIIB)
GlobeNewswire
01/07
BIOGEN INC. (NASDAQ: BIIB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of U...
GlobeNewswire
30/06
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen...
GlobeNewswire
29/06
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against Bio...
GlobeNewswire
29/06
Biogen Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
GlobeNewswire
28/06
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...
GlobeNewswire
28/06
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen
GlobeNewswire
28/06
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
28/06
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GlobeNewswire
28/06
Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire
27/06
DEADLINE ALERT for BIIB, DRCT, FSLY, CRGE: Law Offices of Howard G. Smith Reminds Investors of Class...
GlobeNewswire
27/06
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 M...
GlobeNewswire
27/06
INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial
GlobeNewswire
27/06
BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Sub...
GlobeNewswire
26/06
DEADLINE ALERT for CMBM, BIIB, DRCT, and FSLY: The Law Offices of Frank R. Cruz Reminds Investors of...
GlobeNewswire
25/06
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Fir...
GlobeNewswire
25/06
Biogen Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
GlobeNewswire
24/06
BIOGEN INC. (NASDAQ: BIIB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of U...
GlobeNewswire
24/06
TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union
GlobeNewswire
24/06
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
22/06
Securities Fraud Class Action Lawsuit Was Filed Against Biogen Inc. (BIIB) – Contact Kessler Topaz M...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen...
